Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Dermatology (Basel, Switzerland)|November 26, 2023
Predictors of Recurrence and Progression in Poorly Differentiated Cutaneous Squamous Cell Carcinomas: Insights from a Real-Life ExperienceGabriele Roccuzzo, Giulia Orlando, Maria Rebecca Rumore, et al.
Cells|February 15, 2022
Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score SystemGabriele Roccuzzo, Silvia Giordano, Gianluca Avallone, et al.
Journal of Clinical Medicine|February 25, 2023
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort StudyGianluca Avallone, Carlo Alberto Maronese, Giulia Murgia, et al.
Cancers|September 14, 2024
Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected MelanomaGabriele Roccuzzo, Paolo Fava, Chiara Astrua, et al.
Expert Review of Molecular Diagnostics|February 9, 2024
Emerging prognostic biomarkers in advanced cutaneous melanoma: a literature updateGabriele Roccuzzo, Eleonora Bongiovanni, Luca Tonella, et al.
Cells|February 25, 2025
The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell LymphomasLiyun Lin, Gabriele Roccuzzo, Yuliya Yakymiv, et al.
The Journal of Investigative Dermatology|May 14, 2026
Evaluating T-Cell Clonality In Skin Using a Quantitative TRBC1-Clonality ScoreChristoph Iselin, Pacôme Prompsy, Yi-Chien Tsai, et al.
Expert Opinion on Biological Therapy|July 17, 2023
Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life studyLuca Mastorino, Lorenza Burzi, Giada Frigatti, et al.
Cornea|July 5, 2023
Ocular Surface Disease in Patients With Atopic Dermatitis Treated With Dupilumab: A Prospective Case-Control StudyPaola Marolo, Simone Ribero, Paolo Caselgrandi, et al.
Life (Basel, Switzerland)|September 27, 2025
Cutaneous and Lymphangitic Infection Caused by Purpureocillium lilacinum in Immunocompromised Patients: A Case Report with a Narrative Review of the LiteratureTommaso Lupia, Cristina Sarda, Francesca Canta, et al.
Pageof 6